Interestingly, epithelial cells from chronic obstructive pulmonary disease (COPD) patients displaying increased susceptibility to IAV infections have reduced SOCS5 levels, suggesting SOCS5 substrates may represent new anti-viral drug targets (Kedzierski et al., 2017). The gene discussed is SOCS5; the disease is chronic obstructive pulmonary disease.